Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantation

Author:

Inamoto Yoshihiro1,Matsuda Tomohiro1,Tabuchi Ken2,Kurosawa Saiko1,Nakasone Hideki3,Nishimori Hisakazu4,Yamasaki Satoshi5,Doki Noriko2,Iwato Koji6,Mori Takehiko7,Takahashi Satoshi8,Yabe Hiromasa9,Kohno Akio10,Nakamae Hirohisa11,Sakura Toru12,Hashimoto Hisako13,Sugita Junichi14,Ago Hiroatsu15,Fukuda Takahiro1,Ichinohe Tatsuo16,Atsuta Yoshiko17,Yamashita Takuya18

Affiliation:

1. National Cancer Center Hospital, Tokyo, Japan;

2. Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan;

3. Saitama Medical Center, Jichi Medical University, Saitama, Japan;

4. Okayama University Hospital, Okayama, Japan;

5. National Hospital Organization Kyushu Medical Center, Fukuoka, Japan;

6. Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan;

7. Keio University School of Medicine, Tokyo, Japan;

8. The Institute of Medical Science, The University of Tokyo, Tokyo, Japan;

9. Tokai University Hospital, Isehara, Japan;

10. JA Aichi Konan Kosei Hospital, Konan, Japan;

11. Osaka City University, Osaka, Japan;

12. Saiseikai Maebashi Hospital, Gunma, Japan;

13. Kobe City Medical Center General Hospital, Kobe, Japan;

14. Hokkaido University Hospital, Sapporo, Japan;

15. Shimane Prefectural Central Hospital, Izumo, Japan;

16. Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan;

17. Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan; and

18. St. Luke’s International Hospital, Tokyo, Japan

Abstract

Key Points Subsequent solid cancers after HCT occurred at younger ages than primary cancers and accounted for most common causes of deaths. Subsequent solid cancers after HCT showed similar or worse survival compared with primary cancers in the general population.

Publisher

American Society of Hematology

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3